Andrew J Frankart
Overview
Explore the profile of Andrew J Frankart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Win T, Kharofa J, Frankart A
Support Care Cancer
. 2024 Dec;
33(1):11.
PMID: 39653822
Purpose: Radiation therapy can cause acute and long-term side effects despite advances in treatment delivery techniques. While significant research has been conducted to prevent the occurrence of toxicity, there is...
2.
Petery T, Frankart A, Esslinger H, Wu X, Rai S, Takiar V
Oral Oncol
. 2024 Jun;
154:106870.
PMID: 38823171
Objective(s): To assess the influence of treatment package time (TPT) on overall survival (OS) and event free survival (EFS) in oral cavity cancer (OCC) patients treated with surgery and adjuvant...
3.
Moore A, Nooruddin Z, Reveles K, Koeller J, Whitehead J, Franklin K, et al.
Oncologist
. 2023 Jun;
28(9):804-811.
PMID: 37335901
Background: Real-world evidence is limited regarding the relationship between race and use of durvalumab, an immunotherapy approved for use in adults with unresectable stage III non-small cell lung cancer (NSCLC)...
4.
Frankart A, Abana C, Geier N, Bahig H, Manzar G, Garden A, et al.
Am J Clin Oncol
. 2022 Sep;
45(10):422-426.
PMID: 36083002
Objectives: Unilateral radiation to cervical nodes has been used as a de-escalation strategy in well-lateralized tonsil cancers. The efficacy of this approach with multiple ipsilateral nodes is not established. The...
5.
A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer
Frankart A, Sadraei N, Huth B, Redmond K, Barrett W, Kurtzweil N, et al.
Laryngoscope Investig Otolaryngol
. 2022 Apr;
7(2):437-443.
PMID: 35434343
Objectives: Cisplatin-based chemoradiation is an established organ-preserving strategy for locally advanced laryngeal cancer, but long-term survival remains suboptimal. Immunotherapy has been studied in the metastatic and unresectable recurrent settings. However,...
6.
Frankart A, Takiar V
Int J Radiat Oncol Biol Phys
. 2021 Sep;
111(2):584.
PMID: 34473984
No abstract available.
7.
Frankart A, Breneman J, Pater L
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298780
The use of radiation therapy is an important part of multimodality treatment for rhabdomyosarcoma. The specific doses, treatment volumes, and techniques used in radiation therapy can vary dramatically based upon...
8.
Leddon J, Chirra M, Frankart A, Agrawal A, Roof L, Trotier D, et al.
Laryngoscope
. 2021 Feb;
131(7):E2413-E2419.
PMID: 33609046
Objectives/hypothesis: Hypothyroidism is a relatively common complication of head and neck squamous cell carcinoma (HNSCC) treatment. The objective of this study was to determine whether the addition of programmed death...
9.
Frankart A, Frankart M, Cervenka B, Tang A, Krishnan D, Takiar V
Int J Radiat Oncol Biol Phys
. 2021 Jan;
109(5):1206-1218.
PMID: 33412258
Osteoradionecrosis is a relatively rare but potentially morbid and costly complication of radiation therapy for head and neck cancer. Multidisciplinary diagnosis and treatment are essential. Despite evidence guiding individual aspects...
10.
Frankart A, Criss B, Dillehay McKillip K, Wise-Draper T, Takiar V, Kharofa J
Dis Colon Rectum
. 2021 Jan;
64(4):459-465.
PMID: 33394778
Background: Human papillomavirus has been implicated in the carcinogenesis of squamous cell carcinoma of the anal canal. p16 expression and the presence of human papillomavirus DNA have been used to...